Table 1.
Baseline characteristics of the enrolled 62 patients.
| Characteristics | Number of Cases(%) | Number of Amp11q13 Cases(%) | Number of nonAmp11q13 Cases(%) | chiq P-value |
|---|---|---|---|---|
| Age | 0.19 | |||
| <=60 | 41(66.1) | 12(80) | 29(61.7) | |
| >60 | 21(33.9) | 3(20) | 18(38.3) | |
| Gender | 0.74 | |||
| female | 10(16.1) | 2(13.3) | 8(17) | |
| male | 52(83.9) | 13(86.7) | 39(83) | |
| Cirrhosis | 0.95 | |||
| Non | 8(12.9) | 2(13.3) | 6(12.8) | |
| Yes | 54(87.1) | 13(86.7) | 41(87.2) | |
| AFP | 0.1 | |||
| <200 | 33(53.2) | 5(33.3) | 28(59.6) | |
| >=200 | 27(43.5) | 10(66.7) | 17(36.2) | |
| NA | 2(3.2) | 2(4.3) | ||
| DCP | 0.02 | |||
| <200 | 17(27.4) | 2(13.3) | 15(31.9) | |
| >=200 | 35(56.5) | 13(86.7) | 22(46.8) | |
| NA | 10(16.1) | 10(21.3) | ||
| BCLC.stage | 0.08 | |||
| A/B | 44(71) | 8(53.3) | 36(76.6) | |
| C | 18(29) | 7(46.7) | 11(23.4) | |
| Tumor.number | 0.02 | |||
| 1 | 40(64.5) | 6(40) | 34(72.3) | |
| multiple | 22(35.5) | 9(60) | 13(27.7) | |
| Size | 0.58 | |||
| <=5 | 27(43.5) | 5(33.3) | 22(46.8) | |
| >5 | 30(48.4) | 9(60) | 21(44.7) | |
| NA | 5(8.1) | 1(6.7) | 4(8.5) | |
| Portal.vein.tumor.thrombosis | 0.0004 | |||
| Non | 49(79) | 7(46.7) | 42(89.4) | |
| Yes | 13(21) | 8(53.3) | 5(10.6) | |
| Extrahepatic.metastases | 0.97 | |||
| YES | 4(6.5) | 1(6.7) | 3(6.4) | |
| non | 58(93.5) | 14(93.3) | 44(93.6) | |
| HBsAg | 0.64 | |||
| 0 | 10(16.1) | 3(20) | 7(14.9) | |
| 1 | 52(83.9) | 12(80) | 40(85.1) | |
| HBV.DNA | 0.86 | |||
| >0 | 26(41.9) | 6(40) | 20(42.6) | |
| 0 | 36(58.1) | 9(60) | 27(57.4) | |
| TB | 0.19 | |||
| <13 | 21(33.9) | 3(20) | 18(38.3) | |
| >=13 | 41(66.1) | 12(80) | 29(61.7) | |
| ALB | / | |||
| <50 | 62(100) | 15(100) | 47(100) | |
| ALT | 0.67 | |||
| <41 | 40(64.5) | 9(60) | 31(66) | |
| >=41 | 22(35.5) | 6(40) | 16(34) | |
| AST | 0.08 | |||
| <38 | 36(58.1) | 5(33.3) | 31(66) | |
| >=38 | 24(38.7) | 9(60) | 15(31.9) | |
| NA | 2(3.2) | 1(6.7) | 1(2.1) | |
| type | 0.55 | |||
| HCC | 29(46.8) | 6(40) | 23(48.9) | |
| uHCC | 33(53.2) | 9(60) | 24(51.1) | |
| Treatment.Strategies | 0.89 | |||
| 1st Line PD1Ab | 15(24.2) | 4(26.7) | 11(23.4) | |
| 2nd Line PD1Ab | 5(8.1) | 1(6.7) | 4(8.5) | |
| LRT | 5(8.1) | 1(6.7) | 4(8.5) | |
| NA | 29(46.8) | 6(40) | 23(48.9) | |
| TKIs with or without LRT | 8(12.9) | 3(20) | 5(10.6) |